# Cumberland Pharmaceuticals Inc: Form 8-K, filed Aug 2, 2017

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2017-08-02
- Accepted by EDGAR: Aug 2, 2017, 17:00 ET
- Period: 2017-08-02
- Accession: 0001628280-17-007877
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828017007877/a8k-newdebtagreement.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828017007877/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828017007877/a8k-newdebtagreement.htm

Filed Aug 2, 2017.
Source: SEC EDGAR, the filing index for accession 0001628280-17-007877. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.